- P55.1 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
- The 2024 edition of ICD-10-CM P55.1 became effective on October 1, 2022.
- This is the American ICD-10-CM version of P55.1 – other international versions of ICD-10 P55.1 may differ.
ICD-10-CM P55.1 is grouped within Diagnostic Related Group(s):
- 794 Neonate with other significant problems
Code History
- 2016 (effective 10/1/2015): New code (first year of non-draft ICD-10-CM)
- 2016 (effective 10/1/2015): No change
- 2017 (effective 10/1/2016): No change
- 2018 (effective 10/1/2017): No change
- 2019 (effective 10/1/2018): No change
- 2020 (effective 10/1/2019): No change
- 2021 (effective 10/1/2020): No change
- 2022 (effective 10/1/2021): No change
- 2024 (effective 10/1/2022): No change
Diagnosis Index entries containing back-references to P55.1:
- hemolytic disease (newborn) > Abocclusion M26.29
- due to > newborn P61.4
- ABO (antibodies, isoimmunization, maternal/fetal incompatibility) > due to P55.1
- incompatibility > due to or with
- ABO (blood group) > incompatibility P55.1
- due to > Erythroblastosis (fetalis) (newborn) P55.9
- ABO (antibodies) (incompatibility) (isoimmunization) > due to P55.1
- ABO > Immunization
- in newborn > ABO P55.1
- newborn > ABO O36.11-
- ABO (blood groups) > newborn P55.9
- ABO > due to or associated with
- antibodies > ABO P55.1
- incompatibility, maternal/fetal > ABO P55.1
- isoimmunization > ABO P55.1
- ABO isoimmunization > hemolytic disease P55.9